CCP
TMO icon

Clarkston Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Clarkston Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.55M Sell
3,088
-492
-14% -$236K 0.13% 55
2026
Q1 		$1.76M Sell
3,580
-29,834
-89% -$16.2M 0.13% 62
2025
Q4 		$19.4M Buy
33,414
+196
+0.6% +$111K 0.45% 52
2025
Q3 		$16.1M Sell
33,218
-259
-0.8% -$121K 0.35% 55
2025
Q2 		$13.6M Buy
33,477
+32,802
+4,860% +$13.7M 0.29% 56
2025
Q1 		$336K Hold
675
– – 0.01% 131
2024
Q4 		$351K Hold
675
– – 0.01% 133
2024
Q3 		$418K Sell
675
-41
-6% -$24.3K 0.01% 124
2024
Q2 		$396K Hold
716
– – 0.01% 128
2024
Q1 		$416K Sell
716
-50
-7% -$28.1K 0.01% 127
2023
Q4 		$407K Hold
766
– – 0.01% 122
2023
Q3 		$388K Buy
766
+50
+7% +$26.6K 0.01% 122
2023
Q2 		$374K Hold
716
– – 0.01% 125
2023
Q1 		$413K Hold
716
– – 0.01% 122
2022
Q4 		$394K Sell
716
-21
-3% -$11.1K 0.01% 133
2022
Q3 		$374K Sell
737
-21
-3% -$11.8K 0.01% 134
2022
Q2 		$412K Buy
758
+16
+2% +$8.81K 0.01% 134
2022
Q1 		$438K Sell
742
-129
-15% -$74.1K 0.01% 139
2021
Q4 		$581K Buy
871
+5
+0.6% +$3.12K 0.01% 114
2021
Q3 		$495K Hold
866
– – 0.01% 105
2021
Q2 		$437K Hold
866
– – 0.01% 109
2021
Q1 		$395K Buy
866
+267
+45% +$127K 0.01% 113
2020
Q4 		$279K Buy
599
+87
+17% +$40.8K 0.01% 103
2020
Q3 		$226K Buy
+512
New +$212K 0.01% 101

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Clarkston Capital Partners's TMO Position: Q2 2026 in Review

Clarkston Capital Partners reduced its Thermo Fisher Scientific (TMO) stake by 14% in Q2 2026, selling an estimated $236K and leaving 3,088 shares worth $1.55M. The position accounts for 0.13% of the portfolio, ranked #55.

Clarkston Capital Partners first reported a position in TMO in Q3 2020 and has held it in 24 quarters since. The position peaked at $19.4M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Clarkston Capital Partners held 3,088 shares of Thermo Fisher Scientific worth $1.55M as of Q2 2026.
  • Clarkston Capital Partners sold 492 Thermo Fisher Scientific shares in Q2 2026, an estimated $236K.
  • Thermo Fisher Scientific made up 0.13% of Clarkston Capital Partners's portfolio in Q2 2026, its #55 holding.
  • Clarkston Capital Partners first reported a position in Thermo Fisher Scientific in Q3 2020 and has held it in 24 quarters since.
  • Clarkston Capital Partners's Thermo Fisher Scientific position peaked at $19.4M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Clarkston Capital Partners's 13F filing for Q2 2026, filed 11 Aug 2026.